Inc. today provided full-year Abecma® (idecabtagene vicleucel; ide-cel) sales results for 2024, in partnership with Bristol Myers Squibb (BMS). "We are pleased to see Abecma expansion in the third ...

Do not take DAPA-TABS if you have: severe liver disease or if you suffer from a condition called hepatic encephalopathy ... in the number of platelets which causes easy bruising and nasal bleeding ...

Discover a study in which non-selective β-blockers have demonstrated significant potential in preventing decompensation.

Acute and chronic treatment for hepatic encephalopathy acquired from Mallinckrodt Pharmaceuticals in September 2024Extended pre-clinical, ...

Semin Liver Dis. 2008;28(1):70-80. Magnetic resonance of the brain has become a standard technique for the assessment of patients with neurological manifestations. In patients with cirrhosis ...

This study shows that the incidence of hepatic encephalopathy was lower in cirrhotic patients with upper gastrointestinal bleed treated with lactulose as compared with patients not treated with ...

The health sciences study all aspects of health, disease and healthcare. This field of study aims to develop knowledge, interventions and technology for use in healthcare to improve the treatment ...

There are many potential causes of MCI. Some of them are treatable and get better, while others may not. For many people it’s not possible to know what’s causing their MCI, although it may become ...

1 Department of Paediatric Neurology, Sheffield Children's Hospital, NHS Foundation Trust, Sheffield, UK 2 Department of Paediatric Neuroradiology, Sheffield Children's Hospital, NHS Foundation Trust, ...